Health Sciences Acquisitions Co. 2 (HSAQ) Competitors $2.66 0.00 (0.00%) As of 08/14/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock HSAQ vs. NSPR, CTCX, TMDIF, RVP, PETV, GBS, BTCY, IVF, DYNT, and TTOOShould you be buying Health Sciences Acquisitions Co. 2 stock or one of its competitors? The main competitors of Health Sciences Acquisitions Co. 2 include InspireMD (NSPR), Carmell (CTCX), Titan Medical (TMDIF), Retractable Technologies (RVP), PetVivo (PETV), GBS (GBS), Biotricity (BTCY), INVO Fertility (IVF), Dynatronics (DYNT), and T2 Biosystems (TTOO). These companies are all part of the "surgical & medical instruments" industry. Health Sciences Acquisitions Co. 2 vs. Its Competitors InspireMD Carmell Titan Medical Retractable Technologies PetVivo GBS Biotricity INVO Fertility Dynatronics T2 Biosystems Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations. Does the media refer more to HSAQ or NSPR? In the previous week, InspireMD had 1 more articles in the media than Health Sciences Acquisitions Co. 2. MarketBeat recorded 1 mentions for InspireMD and 0 mentions for Health Sciences Acquisitions Co. 2. InspireMD's average media sentiment score of 0.95 beat Health Sciences Acquisitions Co. 2's score of 0.00 indicating that InspireMD is being referred to more favorably in the news media. Company Overall Sentiment Health Sciences Acquisitions Co. 2 Neutral InspireMD Positive Which has higher earnings & valuation, HSAQ or NSPR? Health Sciences Acquisitions Co. 2 has higher earnings, but lower revenue than InspireMD. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHealth Sciences Acquisitions Co. 2N/AN/A-$380KN/AN/AInspireMD$7.07M14.76-$19.92M-$0.83-3.01 Do analysts prefer HSAQ or NSPR? InspireMD has a consensus price target of $4.50, suggesting a potential upside of 80.00%. Given InspireMD's stronger consensus rating and higher probable upside, analysts clearly believe InspireMD is more favorable than Health Sciences Acquisitions Co. 2.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Health Sciences Acquisitions Co. 2 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00InspireMD 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is HSAQ or NSPR more profitable? Health Sciences Acquisitions Co. 2 has a net margin of 0.00% compared to InspireMD's net margin of -413.96%. Health Sciences Acquisitions Co. 2's return on equity of 0.00% beat InspireMD's return on equity.Company Net Margins Return on Equity Return on Assets Health Sciences Acquisitions Co. 2N/A N/A -2.38% InspireMD -413.96%-69.42%-57.68% Do institutionals and insiders have more ownership in HSAQ or NSPR? 89.7% of Health Sciences Acquisitions Co. 2 shares are held by institutional investors. Comparatively, 44.8% of InspireMD shares are held by institutional investors. 21.9% of Health Sciences Acquisitions Co. 2 shares are held by company insiders. Comparatively, 34.1% of InspireMD shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has more volatility and risk, HSAQ or NSPR? Health Sciences Acquisitions Co. 2 has a beta of 0.09, meaning that its share price is 91% less volatile than the S&P 500. Comparatively, InspireMD has a beta of 0.6, meaning that its share price is 40% less volatile than the S&P 500. SummaryInspireMD beats Health Sciences Acquisitions Co. 2 on 8 of the 13 factors compared between the two stocks. Get Health Sciences Acquisitions Co. 2 News Delivered to You Automatically Sign up to receive the latest news and ratings for HSAQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HSAQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSAQ vs. The Competition Export to ExcelMetricHealth Sciences Acquisitions Co. 2Surgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$29.82M$76.10M$5.67B$9.82BDividend YieldN/AN/A3.79%4.07%P/E RatioN/A10.3230.5825.12Price / SalesN/A86.76464.45115.80Price / CashN/A18.4137.4059.05Price / Book-4.297.429.096.18Net Income-$380K-$25.86M$3.25B$264.89M7 Day Performance-1.85%1.47%7.32%4.18%1 Month Performance-8.90%4.03%5.42%1.99%1 Year Performance-58.57%53.35%30.66%24.22% Health Sciences Acquisitions Co. 2 Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSAQHealth Sciences Acquisitions Co. 2N/A$2.66flatN/A-56.1%$29.82MN/A0.004NSPRInspireMD4.0008 of 5 stars$2.52-2.3%$4.50+78.6%-15.5%$105.14M$7.07M-3.3650CTCXCarmellN/A$2.70-4.6%N/A+142.3%$56.44M$32.84K0.0014TMDIFTitan MedicalN/A$0.37+2.3%N/A+920.5%$42.01M$17.63M-0.2950Gap DownRVPRetractable Technologies1.7442 of 5 stars$0.81-0.9%N/A-20.5%$24.22M$33.75M-1.50240News CoverageShort Interest ↑High Trading VolumePETVPetVivoN/A$0.85-1.3%N/A+57.8%$23.38M$1.05M-1.8920News CoverageGBSGBSN/A$1.44-5.3%N/A+31.0%$21.44MN/A-2.577BTCYBiotricityN/A$0.50+1.8%N/A+50.1%$12.46M$12.06M-0.4640News CoverageGap UpIVFINVO FertilityN/A$1.73-1.1%N/A-94.9%$1.25M$6.53M-0.0225News CoverageEarnings ReportDYNTDynatronicsN/A$0.09+2.3%N/A-37.6%$1.19M$33.60M-0.11200Gap UpTTOOT2 BiosystemsN/A$0.02-5.6%N/A-99.4%$358K$7.68M0.00180Short Interest ↓Gap Down Related Companies and Tools Related Companies InspireMD Competitors Carmell Competitors Titan Medical Competitors Retractable Technologies Competitors PetVivo Competitors GBS Competitors Biotricity Competitors INVO Fertility Competitors Dynatronics Competitors T2 Biosystems Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSAQ) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health Sciences Acquisitions Co. 2 Please log in to your account or sign up in order to add this asset to your watchlist. Share Health Sciences Acquisitions Co. 2 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access